期刊文献+

糖尿病周围神经病变氧化应激等相关机制探讨 被引量:44

Investigation the mechanism of oxidative stress in diabetic peripheral neuropathy
下载PDF
导出
摘要 目的探讨氧化应激在糖尿病周围神经病变(diabetic peripheral neuropathy,DPN)机制中的作用。方法总结50例DPN患者与27例2型糖尿病非周围神经病变(NDPN)患者临床资料,包括收缩压(SBP)、舒张压(DBP)、体质指数(BMI)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(Hb A1c)、空腹血糖(FPG)、餐后2 h血糖(2h PG)、空腹C肽(FC-P)、2 h C肽(2h C-P)水平。测定并分析患者血清总抗氧化能力(T-AOC)、丙二醛(MDA)及超氧化物歧化酶(SOD)水平。对有统计学意义的危险因素进行Logistic多元回归分析,以发现DPN发生的危险因素。结果 DPN组与NDPN组比较,性别、BMI、SBP、DBP、2h PG、FC-P、TC、HDL-C、LDL-C、Hb A1c、T-AOC差异均无统计学意义(P>0.05),而年龄、病程、FPG、TG、2h C-P、SOD、MDA有显著差异(P<0.05);多因素Logistic回归分析年龄、TG、2h C-P、MDA进入回归方程;MDA、SOD与TCSS评分呈相关性(P<0.05)。结论年龄、TG、2h C-P、MDA是DPN发生的独立危险因素;血清SOD水平的下降、MDA水平的增高与DPN的发生及神经病变程度显著相关,氧化应激在DPN发病机制中起重要作用。 Objective To investigate the role of oxidative stress in the mechanism of diabetic peripheral neuropa-thy (DPN) and to analyze the risk factors for the development of DPN. Methods Fifty DPN patients and 27 patients diag-nosed with type 2 diabetes mellitus (T2DM) without DPN (NDPN) were enrolled into this study. The clinical data of pa-tients, including systolic pressure (SBP), diastolic pressure (DBP), body mass index (BMI), triglyceride (TG), total choles-terol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), Hemoglobin A1C (HbA1c), fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (2hPG), fasting C peptide (FC-P), 2-hour C peptide (2hC-P) were recorded and analyzed. Total antioxidant capacity (T-AOC), Malondialdehyde (MDA) and superoxide dismutase (SOD) levels were examined to evaluate the level of oxidative stress. The risk factors with statistical significance were subjected to multiple Logistic regression analysis to screen for the risk factors for DPN. Results There was no signif-icant difference in sex, BMI, SBP, DBP, 2hPG, FC-P, TC, HDL-C, LDL-C, HbA1c, T-AOC between the 2 groups of pa-tients (P 〉0.05), while age, duration of DM, FPG, TG, 2hC-P, SOD, MDA were statistically different (P 〈 0.05). By multi-factor Logistic regression analysis, age, TG, 2hC-P, MDA came into the regression equation;MDA and SOD cor-related with the TCSS score (P〈 0.05). Conclusion Age, TG, 2hC-P, MDA levels are the independent risk factors for DPN, The decrease of SOD level and increase of MDA are interrelated with DPN, and the levels of SOD and MDA are as-sociated with the degree of functional nerve damage. Oxidative stress plays an important role in the pathogenesis of DPN.
出处 《北京医学》 CAS 2015年第1期16-19,共4页 Beijing Medical Journal
基金 山东省中医药科技发展计划项目(2011-230)
关键词 糖尿病周围神经病变 总抗氧化能力 丙二醛 超氧化物歧化酶 多伦多临床评分系统 Diabetic peripheral neuropathy Total antioxidant blood capacity Malondialdehyde superoxide dismutase Toronto clinical scoring system
  • 相关文献

参考文献13

  • 1Brownlee M. The pathobiology of diabetic complications: a unify-ing mechanism[J]. Diabetes, 2005,54:1615-1625.
  • 2Kasznicki J, Kosmalski M,Sliwinska A,et al. Evaluation of oxi-dat-ive stress markers in pathogenesis of diabetic neuropathy [J],Mol Biol Rep, 2012,39:8669-8678.
  • 3Nourooz-Zadeh J, Ziegler D, Sohr C, et al. The use of pholasin asa probe for the determination of plasma total antioxidant capacity[J], Clin Biochem, 2006, 39:55-61.
  • 4Dordevic G,Duric S, Apostolskit S,et al. Total antioxidant bloodcapacity in patients with type 2 diabetes mellitus and distal sym-metrical polyneur- opathy[J]. Vojnosanit Pregl, 2008,65:663-669.
  • 5刘利群,毛定安,薄涛,熊洁.川芎嗪对幼鼠惊厥性脑损伤脂质过氧化及抗氧化水平的影响[J].中国医院药学杂志,2008,28(4):253-256. 被引量:10
  • 6Pasaoglu H, Sancak B, Bukan N. Lipid peroxidation and resis-tance to oxidation in patients with type 2 diabetes mellitus[J]. To-hoku J Exp Med, 2004, 203:211-218.
  • 7Andrea M. Vincent, James W. Russell,Kelli A. Sullivan, et al.S0D2 protects neurons from injury in cell culture and ani-mal models of diabetic neuropathy [J]. Exp Neu-rol, 2007, 208:216-227.
  • 8范宾科,谢云.糖尿病周围神经病变的相关因素分析[J].天津医药,2009,37(7):600-601. 被引量:17
  • 9Wiggin TD, Sullivan BCA, Pop -Busui R, et al. Elevated triglyc-erides correlate with progression of diabetic neuropathy [J]. Dia-betes, 2009, 58:1634-1640.
  • 10卢曙芳,陈伟宁,朱麒钱.C肽水平与2型糖尿病周围神经病变的关系研究[J].中国全科医学,2011,14(9):954-956. 被引量:19

二级参考文献36

  • 1程先超,刘新泳,徐文方.川芎嗪心脑血管药理学研究进展[J].中国医院药学杂志,2005,25(7):661-663. 被引量:71
  • 2刘利群,毛定安,薄涛,白海涛,莫双红,熊洁.川芎嗪对发育期大鼠惊厥性脑损伤海马ATP酶与脑含水量变化的影响[J].中国急救医学,2006,26(7):518-520. 被引量:4
  • 3贾伟平,沈琴,包玉倩,陆俊茜,李鸣,项坤三.糖尿病周围神经病变的检测方法及其诊断价值的评估[J].中华医学杂志,2006,86(38):2707-2710. 被引量:86
  • 4李一君,母义明.血糖强化达标的新策略:胰岛素泵治疗和动态血糖监测的临床应用[J].中国实用内科杂志,2007,27(7):502-504. 被引量:47
  • 5Wright A, Burden ACF, Paisey RB, et al. Sulfonylurea inadequa- cy: Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care,2002,25:330-336.
  • 6Bermudez-Pirela VJ, Cano C, Medina MT, et al. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance [HOMA (IR)] and be- ta-cell function [HOMA (beta-cell)] without hyperinsulinemia in patients with type 2 diabetes mellitus. Am J Ther,2007,14: 194-202.
  • 7Ronald kahn C,Weir GC,King GL,et al.Joslin糖尿病学.潘长玉,陈家伟,陈明道,等,译.14版.北京:人民卫生出版社,2007:678-744.
  • 8Weng J, Li Y, Xu W. Effect of intensive insulin therapy on be- ta-cell function and glycaemic control in patients with newly di- agnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet,2008,371:1753-1760.
  • 9Nathan DM, Buse JB, David MB, et al. Management of hyper- glycemia in type 2 diabetes: A consensus algorithm for the initia- tion and adjustment of therapy. Diabetes Care, 2006,29 1963-1972.
  • 10Sima AA. Pathological mechanisms involved in diabetic neuropathy: can we slow the process [ J ]. Curr Opin Investig Drugs, 2006, 7 (4) : 324 - 337.

共引文献78

同被引文献423

引证文献44

二级引证文献484

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部